PCM
AMGN icon

Pennsylvania Capital Management’s Amgen AMGN Stock Holding History

Pennsylvania Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,315
Closed -$782K – 63
2020
Q2 		$782K Buy
+3,315
New +$756K 0.42% 49

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pennsylvania Capital Management's AMGN Position: Q3 2020 in Review

Pennsylvania Capital Management sold out of Amgen (AMGN) in Q3 2020, closing a stake of 3,315 shares — an estimated $782K sold.

Pennsylvania Capital Management first reported a position in AMGN in Q2 2020 and held it in 1 quarter. The position peaked at $782K in Q2 2020. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Pennsylvania Capital Management reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Pennsylvania Capital Management sold 3,315 Amgen shares in Q3 2020, an estimated $782K.
  • Pennsylvania Capital Management first reported a position in Amgen in Q2 2020 and held it in 1 quarter.
  • Pennsylvania Capital Management's Amgen position peaked at $782K in Q2 2020.
  • 2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Pennsylvania Capital Management's 13F filing for Q3 2020, filed 7 Oct 2020.